About 200 reports

Type 2 Diabetes - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes - Pipeline Review, H2 2020, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition and is...

  • Type 2 Diabetes
  • Endocrine Disease
  • World

Type 2 Diabetes - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H1 2020, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape. Type 2 diabetes is a chronic condition...

  • Type 2 Diabetes
  • Endocrine Disease
  • World

Type ## Diabetes:

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Overweight Prevalence

Global Type 2 Diabetes Market 2021-2025 The analyst has been monitoring the type 2 diabetes market and it is poised to grow by $ 29.91 billion during 2021-2025, progressing at a CAGR of about 10% during the forecast period. Our report on the type 2 diabetes market provides a holistic analysis, market size and forecast,...

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Overweight Prevalence

Small Molecules to Agonize GIPR and GLP##R for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Dementia
  • Pharmaceutical
  • World
  • Energy Consumption

Small Molecule to Activate Glucokinase for Type ## Diabetes – Drug Profile

  • Therapy
  • Type 2 Diabetes
  • Diabetes
  • Drug Development
  • World
  • Diabetes Prevalence
  • Medicine Use

Small Molecules to Agonize GIPR and GLP##R for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Dementia
  • Pharmaceutical
  • World
  • Energy Consumption
  • Diabetes Prevalence

Type ## Diabetes

  • Type 2 Diabetes
  • World
  • Japan
  • Smoking Prevalence

Small Molecule to Agonize GPR## for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Pharmaceutical Exports

Small Molecule to Agonize GPR## for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Pharmaceutical Exports

Small Molecules to Inhibit PTP##B for Type ## Diabetes and Obesity – Drug Profile

  • Type 2 Diabetes
  • World
  • Food Consumption

Small Molecule to Agonize GPR-## for Type ## Diabetes

  • Type 2 Diabetes
  • Pharmaceutical
  • World
  • Japan
  • Smoking Prevalence
  • Lead Export

Blood Glucose Device Market, Users Global Forecast, SMBG Components of 17 Countries (America, Europe, Asia & Pacific, MENA) & Companies According to International diabetes federation, in 2017, there are around 425 million of people living with diabetes in the world. Diabetes people all over the world...

  • Diabetes
  • Diabetes Monitoring
  • Patient Monitoring
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Insulin
  • World
  • China
  • Overweight Prevalence
  • Gross Domestic Product Per Capita

Small Molecule to Agonize GPR## for Type ## Diabetes Johnson & Johnson NA NA

  • Type 2 Diabetes
  • World

Small Molecules to Agonize GPBAR## for Type ## Diabetes Cadila Healthcare Ltd NA NA

  • Type 2 Diabetes
  • World

Small Molecule to Agonize GPR## for Type ## Diabetes Johnson & Johnson NA NA

  • Type 2 Diabetes
  • World

Small Molecules to Agonize GPBAR## for Type ## Diabetes Cadila Healthcare Ltd NA NA

  • Type 2 Diabetes
  • World

Synthetic Peptide ## for Type ## Diabetes, Obesity and Alzheimer's Disease – Drug Profile

  • Type 2 Diabetes
  • Drug Development
  • Therapy
  • Obesity
  • Dementia
  • Endocrine Disease
  • World
  • Diabetes Prevalence
  • Energy Consumption

Small Molecules to Inhibit Heparanase for Type ## and Type ## Diabetes and Age Related Macular Degeneration – Drug Profile

  • Therapy
  • Drug Development
  • Oncology
  • Type 2 Diabetes
  • World

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diabetic Retinopathy Disease Understanding Diabetic...

  • Type 2 Diabetes
  • United States
  • Germany
  • Italy
  • United Kingdom
  • Spain
  • France
  • Japan
  • Diabetes Prevalence

Small Molecule to Activate Glucokinase for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • Therapy
  • World
  • Diabetes Prevalence
  • Medicine Use

China Germany United Kingdom Type ## Diabetes

  • Type 2 Diabetes
  • World
  • Diabetes Prevalence
  • Hospital Occupancy Rate

‘Diabetic Retinopathy (DR) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Diabetic Retinopathy, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Diabetic Retinopathy Disease Understanding Diabetic...

  • Type 2 Diabetes
  • World
  • United States
  • Germany
  • Italy
  • United Kingdom
  • Spain
  • France
  • Japan
  • Diabetes Prevalence

Small Molecule to Activate Glucokinase for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • World
  • Medicine Use

DermaPro World Type ## Diabetes

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Employment Income

Small Molecules to Inhibit PTP##B for Type ## Diabetes and Obesity – Drug Profile

  • Type 2 Diabetes
  • World
  • Food Consumption

Small Molecules to Agonize GPR## for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • Pharmaceutical
  • World
  • Japan
  • Smoking Prevalence
  • LED Export

Small Molecule to Agonize GPR## for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • World
  • Pharmaceutical Exports

FirstString DermaPro World Type ## Diabetes

  • Type 2 Diabetes
  • World
  • Drug Approval
  • Medical Technology Density

Monoclonal Antibodies to Inhibit Islet Amyloid Polypeptide for Type ## Diabetes – Drug Profile

  • Type 2 Diabetes
  • Diabetes
  • Dementia
  • World
  • Northern Europe
  • Indiana
  • Food Consumption
  • Diabetes Prevalence